Chromosomal aberrations by comparative genomic hybridization in Hürthle cell thyroid carcinomas are associated with tumor recurrence

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 10, 2002, Pages 4595-4601

  Wada, Nobuyuki ^a   Duh, Quan Yang ^b   Miura, Daishu ^c   Brunaud, Laurent ^d   Wong, Mariwil G ^e   Clark, Orlo H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CHROMOSOME 12P; CHROMOSOME 12Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 19P; CHROMOSOME 19Q; CHROMOSOME 20P; CHROMOSOME 20Q; CHROMOSOME 22Q; CHROMOSOME 5P; CHROMOSOME 5Q; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PREDICTION; PRIORITY JOURNAL; THYROID ADENOMA; THYROID CARCINOMA; THYROID PARAFOLLICULAR CELL; TUMOR DIFFERENTIATION; UNITED STATES;

ADENOMA; ADENOMA, OXYPHILIC; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 19; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 20; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; THYROID NEOPLASMS;

EID: 0036774403     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020339     Document Type: Article

References (38)

1. Gosain AK, Clark OH 1984 Hurthle cell neoplasms. Malignant potential. Arch Surg 119:515-519
2. Grossman RF, Clark OH 1997 Hurthle cell carcinoma. Cancer Control 4:13-17
3. DeGroot LJ, Kaplan EL, Shukla MS, Salti G, Straus FH 1995 Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab 80:2946-2953
4. Caplan RH, Abellera RM, Kisken WA 1994 Hurthle cell neoplasms of the thyroid gland: Reassessment of functional capacity. Thyroid 4:243-248
5. Shaha AR, Loree TR, Shah JP 1995 Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118:1131-1138
6. Sanders LE, Silverman M 1998 Follicular and Hurthle cell carcinoma: Predicting outcome and directing therapy. Surgery 124:967-974
7. Thompson NW, Dunn EL, Batsakis JG, Nishiyama RH 1974 Hurthle cell lesions of the thyroid gland. Surg Gynecol Obstet 139:555-560
8. Gundry SR, Burney RE, Thompson NW, Lloyd R 1983 Total thyroidectomy for Hurthle cell neoplasm of the thyroid. Arch Surg 118:529-532
9. Arganini M, Behar R, Wu TC, Straus 2nd F, McCormick M, DeGroot LJ, Kaplan EL 1986 Hurthle cell tumors: A twenty-five-year experience. Surgery 100:1108-1115
10. Sugino K, Ito K, Mimura T, Kameyama K, Iwasaki H, Ito K 2001 Hurthle cell tumor of the thyroid: Analysis of 188 cases. World J Surg 25:1160-1163
11. Bronner MP, Clevenger CV, Edmonds PR, Lowell DM, McFarland MM, LiVolsi VA 1988 Flow cytometric analysis of DNA content in Hürthle cell adenomas and carcinomas of the thyroid. Am J Clin Pathol 89:764-769
12. Ryan JJ, Hay ID, Grant CS, Rainwater LM, Farrow GM, Goellner JR 1988 Flow cytometric DNA measurements in benign and malignant Hürthle cell tumors of the thyroid. World J Surg 12:482-487
13. Camargo RS, Scafuri AG, de Tolosa EM, Ferreira EA 1992 DNA image cytometric analysis of differentiated thyroid adenocarcinoma specimens. Am J Surg 164:640-645
14. Salmon I, Gasperin P, Remmelink M, Rahier I, Rocmans P, Pasteels JL, Heimann R, Kiss R 1993 Ploidy level and proliferative activity measurements in a series of 407 thyroid tumors or other pathologic conditions Hum Pathol 24:912-920
15. Roque L, Serpa A, Clode A, Castedo S, Soares J 1999 Significance of trisomy 7 and 12 in thyroid lesions with follicular differentiation: A cytogenetic and in situ hybridization study. Lab Invest 79:369-378
16. Mazzucchelli L, Burckhardt E, Hirsiger H, Kappeler A, Laissue JA 2000 Interphase cytogenetics in oncocytic adenomas and carcinomas of the thyroid gland. Hum Pathol 31:854-859
17. Erickson LA, Jalal SM, Goellner JR, Law ME, Harwood A, Jin L, Roche PC, Lloyd RV 2001 Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization. Am J Surg Pathol 25:911-917
18. Hemmer S, Wasenius VM, Knuutila S, Joensuu H, Franssila K 1998 Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization. Br J Cancer 78:1012-1017
19. Frisk T, Kytölä S, Wallin G, Zedenius J, Larsson C 1999 Low frequency of numerical chromosomal aberrations in follicular thyroid tumors detected by comparative genomic hybridization. Genes Chromosomes Cancer 25:349-353
20. Tallini G, Hsueh A, Liu S, Garcia-Rostan G, Speicher MR, Ward DC 1999 Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization. Lab Invest 79:547-555
21. Chen X, Knauf JA, Gonsky R, Wang M, Lai EH, Chissoe S, Fagin JA, Korenberg JR 1998 From amplification to gene in thyroid cancer: A high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization. Am J Hum Genet 63:625-637
22. Zitzelsberger H, Lehmann L, Hieber L, Weier HU, Janish C, Fung J, Negele T, Spelsberg F, Lengfelder E, Demidchik EP, Salassidis K, Kellerer AM, Werner M, Bauchinger M 1999 Cytogenetic changes in radiation-induced tumors of the thyroid. Cancer Res 59:135-140
23. Hemmer S, Wasenius VM, Knuutila S, Franssila K, Joensuu H 1999 DNA copy number changes in thyroid carcinoma. Am J Pathol 154:1539-1547
24. Komoike Y, Tamaki Y, Sakita I, Tomita N, Ohue M, Sekimoto M, Miyazaki M, Kadota M, Masuda N, Ooka M, Ohnishi T, Nakano Y, Kozaki T, Kobayashi T, Matsuura N, Ikeda T, Horii A, Monden M 1999 Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinoma. Int J Oncol 14:1157-1162
25. Wilkens L, Benten D, Tchinda J, Brabant G, Potter E, Dralle H, von Wasielewski R 2000 Aberrations of chromosomes 5 and 8 as recurrent cytogenetic events in anaplastic carcinoma of the thyroid as detected by fluorescence in situ hybridisation and comparative genomic hybridisation. Virchows Arch 436:312-318
26. Singh B, Lim D, Cigudosa JC, Ghossein R, Shaha AR, Poluri A, Wreesmann VB, Tuttle M, Shah JP, Rao PH 2000 Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization. Surgery 128:888-893
27. Frisk T, Zedenius J, Lundberg J, Wallin G, Kytölä S, Larsson C 2001 CGH alterations in medullary thyroid carcinomas in relation to the RET M918T mutation and clinical outcome. Int J Oncol 18:1219-1225
28. Kjellman P, Lagercrantz S, Höög A, Wallin G, Larsson C, Zedenius J 2001 Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma. Genes Chromosomes Cancer 32:43-49
29. Sambrook J, Maniatis T, Fritsch EF 1989 Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 9.16-9.23
30. Chin K, Gray JW 1998 PCR Applications: Comparative Genomic Hybridization. San Diego: Academic Press; 473-484
31. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D 1992 Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821
32. Belge G, Thode B, Rippe V, Bartnitzke S, Bullerdiek J 1994 A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors. Hum Genet 94:198-202
33. Broberg K, Toksvig-Larsen S, Lindstrand A, Mertens F 2001 Trisomy 7 accumulates with age in solid tumors and non-neoplastic synovia. Genes Chromosomes Cancer 30:310-315
34. Belge G, Roque L, Soares J, Bruckmann S, Thode B, Fonseca E, Clode A, Bartnitzke S, Castedo S, Bullerdiek J 1998 Cytogenetic investigations of 340 thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology. Cancer Genet Cytogenet 101:42-48
35. Criado B, Barros A, Suijkerbuijk RF, Weghuis DO, Seruca R, Fonseca E, Castedo S 1995 Detection of numerical alterations for chromosomes 7 and 12 in benign thyroid lesions by in situ hybridization. Histological implications. Am J Pathol 147:136-144
36. Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J, Levillain P, Romeo G, Bonneau D 1998 A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63:1743-1748
37. Kraimps JL, Canzian F, Jost C, Menet E, Amati P, Levillian P, Harach R, Lesueur F, Barbier J, Romeo G, Bonneau D 1999 Mapping of a gene predisposing to familial thyroid tumors with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate gene. Surgery 126:1188-1194
38. Chen H, Nicol TL, Zeiger MA, Dooley WC, Ladenson PW, Cooper DS, Ringel M, Parkerson S, Allo M, Udelsman R 1998 Hurthle cell neoplasms of the thyroid: Are there factors predictive of malignancy? Ann Surg 227:542-546